Abstract

Background: Novel corona virus (SARS-Coronavirus-2 SARS-CoV-2) which emerged in China has spread to multiple countries rapidly. Little information is known about delayed viral clearance in mild to moderate COVID-19 pa-tients. As it is highly contagious, health care workers including physicians are high risk of being infected in hospital care. Case Report: A 37 years old Bangladeshi physician working in a paediatric unit of a medical college hos-pital with multiple co-morbidities, hypertension, diagnosed axial spondy-loarthropathy (ankylosing spondylitis) taking disease modifying anti rheu-matic drugs— DMARDs (Salfasalazine) from 2016 till now, chronic persis-tent bronchial asthma on medication developed sore throat, increasing breathlessness and cough admitted to his own hospital on 22 April, 2020. He had a history of contact with a relapse nephrotic syndrome (glomerulone-phritis) patient admitted with severe respiratory distress later confirmed as COVID-19 following RT PCR test on 14 April, 2020. After 3 days of contact with the patient, the physician also developed the symptoms mentioned above. The RT PCR test result of the physician came positive on 18 April, 2020. The physician primarily taken only azithromycin 500 mg once daily along with other regular drugs. On 5, 12 and 18 May, 2020, his sample was taken for re-test and came positive subsequently. After that he started Iver-mectin (0.15 mg/kg) once daily for 3 days and doxycycline 100 mg BD for 7 days. He gave samples again on 27 and 29 May, 2020 which were came nega-tive after 39 days. On full recovery he was discharged from hospital on day 40. We choose the patient because presence of co-morbidities may be asso-ciated with delayed viral clearance and physicians with co-morbidities working in a hospital have high risk of being infected.

Highlights

  • The Current outbreak of novel corona virus (2019-nCoV) was first reported in China, on 31st December 2019

  • Case Report: A 37 years old Bangladeshi physician working in a paediatric unit of a medical college hospital with multiple co-morbidities, hypertension, diagnosed axial spondyloarthropathy taking disease modifying anti rheumatic drugs— Disease Modifying Anti-rheumatic drugs (DMARDs) (Salfasalazine) from 2016 till chronic persistent bronchial asthma on medication developed sore throat, increasing breathlessness and cough admitted to his own hospital on 22 April, 2020

  • He had a history of contact with a relapse nephrotic syndrome patient admitted with severe respiratory distress later confirmed as COVID-19 following RT PCR test on 14 April, 2020

Read more

Summary

Introduction

The Current outbreak of novel corona virus (2019-nCoV) was first reported in China, on 31st December 2019. On admission 20-51% of patients having at least one co-morbidity, with diabetes (10% - 20%), hypertension (10% - 15%) and other cardiovascular and cerebrovascular disease (7% - 40%) being most common [3] [4] [6]. SARS-CoV-2 viral clearance is a gold standard for defining the recovery of COVID-19 infections [6]. One study showed that hypertension and diabetes delay the viral clearance in COVID-19 patients [6]. Patients of COVID-19 with multiple co-morbidities have more chance of developing complications as well as delayed viral clearance. We reported a case of 37 years old physician presented with COVID-19 with Hypertension, Bronchial asthma, Ankylosing spondylitis with delayed viral clearance though not developed any severe complications

Case Presentation
Discussions
Result
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call